Acupuncture for Patients With Major Depressive Disorder
1 other identifier
interventional
123
0 countries
N/A
Brief Summary
Several studies investigating acupuncture for major depressive disorder (MDD) have been carried out. However, investigators found the results were in high heterogeneity and poor methodological quality. Thus, investigators intend to provide high quality of the effectiveness and safety of acupuncture for MDD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable major-depressive-disorder
Started Nov 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedFirst Posted
Study publicly available on registry
November 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedNovember 4, 2021
October 1, 2021
1.2 years
October 25, 2021
October 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
score of Hamilton Depression Rating Scale-24
Reduction in the severity of depression, measured at the end of the intervention primarily as a continuous variable on the Hamilton Depression Rating Scale (HAMD)-24
change from baseline to 4 weeks after intervention, after follow-up(4 week)
Secondary Outcomes (11)
score of self-rating depression scale
baseline, after intervention(4 week), after follow-up(4 week)
score of Hamilton Anxiety Rating Scale
baseline, after intervention(4 week) , after follow-up(4 week)
score of Social Disability Screening Schedule
baseline, after intervention(4 week) , after follow-up(4 week)
score of Pittsburgh sleep quality index (PSQI)
baseline, after intervention(4 week) , after follow-up(4 week)
motor threshold (MT)
baseline, after intervention(4 week) , after follow-up(4 week)
- +6 more secondary outcomes
Study Arms (3)
acupuncture
EXPERIMENTAL5 sessions of acupuncture per week for 4 weeks. In each session, acupuncture will be applied bilaterally on acupoints. We will use transcutaneous electric acupoints stimulation (HANS; Han's acupoints nerve stimulator, HANS-200, Nanjing, China) to stimulate the acupoints. Each session will last 30 minutes.
sham acupuncture
SHAM COMPARATOR5 sessions of sham acupuncture per week for 4 weeks. In each session, acupuncture will be applied bilaterally on non-acupoints. We will use transcutaneous electric acupoints stimulation (HANS; Han's acupoints nerve stimulator, HANS-200, Nanjing, China) to stimulate the non-acupoints. Each session will last 30 minutes.
waiting-list
NO INTERVENTIONInterventions
Acupuncture is a form of alternative medicine and a component of traditional Chinese medicine (TCM) in which thin needles are inserted into the acupoints on body to treat diseases.
Eligibility Criteria
You may qualify if:
- Right-handed participants aged between 18 to 60 years;
- participants diagnosed with mild to moderate major depressive disorder(MDD), and meet the diagnostic criteria of mild to moderate MDD according to the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition (DSM-5);
- participants with score of HAMD-24 between 8 to 35;
- participants without anti-depressive medication more than 3 months;
- participants willing to comply with the study protocol;
- participants willing to sign informed consent form.
You may not qualify if:
- participants with severe medical visceral condition and chronic diseases, such as hypertension, coronary heart disease, hyperthyroidism, hypothyroidism or diabetes and other endocrine system diseases;
- participants with brain organic diseases: such as birth injury, trauma, encephalitis, tumor, etc.;
- participants with Peripheral nerve and muscular system diseases;
- participants with severe anxiety, obsessive-compulsive disorder, or a history of mania or hypomania;
- Recently taken drugs that may cause mood disorders;
- Severe bleeding tendency, allergic constitution and skin disease patients;
- pregnant or lactation women;
- Persons with visual and hearing disabilities;
- Participants with pacemakers, deep brain stimulators, vagus nerve stimulators, metal internal fixators, etc
- participate in other clinical trials at the same time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jian Huang
Institute of Science and Technology Development, Sichuan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 25, 2021
First Posted
November 4, 2021
Study Start
November 1, 2021
Primary Completion
December 30, 2022
Study Completion
June 30, 2023
Last Updated
November 4, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share